Physician profile
Angela R Oder
NPI 1235562125
$2,227.22
in general payments reported to CMS, 2019-2025
20 companies · $1,476 in 2025
The $1,476 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.35 · 2023: $431 · 2024: $244 · 2025: $1,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,903 · Education: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,903.48 |
| Education | $247.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $312.22 | 2023-2025 | Trikafta |
| Insmed, INC. | $259.53 | 2023-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $212.53 | 2025 | Dupixent |
| Abbvie INC. | $188.65 | 2023-2025 | |
| Edwards Lifesciences Corporation | $165.49 | 2025 | Sapien 3 Ultra Resilia |
| Genzyme Corporation | $139.04 | 2025 | |
| Biotronik Nro, INC. | $132.15 | 2025 | Prospera |
| Harmony Biosciences LLC | $112.29 | 2025 | |
| Mylan Specialty L.P. | $110.45 | 2023-2024 | |
| Baxter Healthcare | $103.08 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Aimmune Therapeutics, INC. | $98.41 | 2024 | |
| Chiesi USA, INC. | $89.17 | 2021-2023 | Bronchitol |
| Novo Nordisk INC | $85.63 | 2025 | |
| Viatris Specialty LLC | $58.95 | 2025 | Yupelri |
| Jazz Pharmaceuticals INC. | $43.12 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $34.99 | 2023-2024 | Remodulin, Orenitram |
| Dexcom, INC. | $33.48 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $16.77 | 2025 | Winrevair |
| Actelion Pharmaceuticals US, INC. | $15.70 | 2023 | Uptravi, Opsumit |
| Azurity Pharmaceuticals, INC. | $15.57 | 2024 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Oder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.